Exosomal signaling from type 2 diabetes alters tumor–immune crosstalk, driving immunosuppression and tumor aggressiveness in breast cancer organoids through expansion of dysfunctional T cells and activation of invasive programs.
- Christina S. Ennis
- Michael Seen
- Gerald V. Denis